Molecular Data Stock Current Ratio
| MKDTYDelisted Stock | USD 0.01 0.01 2,567% |
Molecular Data fundamentals help investors to digest information that contributes to Molecular Data's financial success or failures. It also enables traders to predict the movement of Molecular Pink Sheet. The fundamental analysis module provides a way to measure Molecular Data's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Molecular Data pink sheet.
Molecular |
Molecular Data Company Current Ratio Analysis
Molecular Data's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
CompetitionIn accordance with the recently published financial statements, Molecular Data has a Current Ratio of 0.0 times. This is 100.0% lower than that of the Basic Materials sector and 100.0% lower than that of the Chemicals industry. The current ratio for all United States stocks is 100.0% higher than that of the company.
Molecular Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Molecular Data's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Molecular Data could also be used in its relative valuation, which is a method of valuing Molecular Data by comparing valuation metrics of similar companies.Molecular Data is currently under evaluation in current ratio category among its peers.
About Molecular Data Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Molecular Data's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Molecular Data using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Molecular Data based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Molecular Pink Sheet
If you are still planning to invest in Molecular Data check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Molecular Data's history and understand the potential risks before investing.
| Stocks Directory Find actively traded stocks across global markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |